FDA Adverse Event Malfunction Summary report: N

HORIZON TI ML 6/CART 120/BOX

MDR report key: 24705538 · Received March 26, 2026

Report

Report Number
3003898360-2026-00147
Event Type
Malfunction
Date Received
March 26, 2026
Date of Event
March 2, 2026
Report Date
March 3, 2026
Manufacturer
TELEFLEX MEDICAL
Product Code
FZP
UDI-DI
14026704725325
PMA / PMN Number
K982313
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

(B)(4). COMPLAINT VERIFICATION TESTING COULD NOT BE PERFORMED AS NO SAMPLE WAS RETURNED FOR ANALYSIS. A DEVICE HISTORY RECORD REVIEW WAS PERFORMED, AND NO RELEVANT FINDINGS WERE IDENTIFIED. WITHOUT THE DEVICE TO EVALUATE THE COMPLAINT COULD NOT BE CONFIRMED AND THE PROBABLE CAUSE COULD NOT BE DETERMINED FROM THE AVAILABLE INFORMATION. IF THE SAMPLE BECOMES AVAILABLE AT A LATER DATE A FOLLOW-UP REPORT WILL BE SUBMITTED WITH INVESTIGATION RESULTS. TELEFLEX WILL CONTINUE TO MONITOR AND TREND FOR REPORTS OF THIS NATURE. OTHER REMARKS: N/A. CORRECTED DATA: N/A.

Description of Event or Problem · 0

IT WAS REPORTED THAT "WHEN THE SURGEON CLIPS A VESSEL (CLOSES THE APPLIER), THE CLIP REMAINS STUCK TO THE APPLIER AND TEARS THE VESSEL WHEN THEY TRY TO REMOVE THE APPLIER. PATIENT ADMITTED FOR MAJOR SURGERY (HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY - HIPEC) DURING WHICH SIGNIFICANT BLOOD LOSS OCCURRED. THE MEDICAL REPORT STATES THAT THE DEVICE IS NOT SPECIFICALLY INVOLVED. BLOOD LOSS IS ESTIMATED AT 1.15 L WITH A URINE OUTPUT OF 1.8 L. THE PATIENT RECEIVED 12 L OF FLUID RESUSCITATION, INCLUDING 9.5 L OF NACL AND 2.5 L OF ISOFUNDIN, AS WELL AS 4 DOSES OF 20% ALBUMIN. THE PATIENT RECEIVED A TRANSFUSION OF 2 UNITS OF PACKED RED BLOOD CELLS DURING THE OPERATION. PATIENT ADMITTED TO THE ICU POST-OPERATIVELY WITH CLOSE MONITORING."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
765254 HORIZON TI ML 6/CART 120/BOX CLIP, IMPLANTABLE FZP TELEFLEX MEDICAL IPN920981 73F2500764 14026704725325

Patients

Seq Age Sex Outcome Treatment
1 71 YR Female NONE REPORTED.